These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8221347)

  • 1. Coronary thrombolysis and previous SK therapy.
    Massel D
    Can J Cardiol; 1993; 9(6):518-20. PubMed ID: 8221347
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.
    Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-streptokinase antibodies].
    Helft G; Lecompte T; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):975-80. PubMed ID: 9339259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the antigenic regions of streptokinase in humans after streptokinase therapy.
    Torréns I; Reyes O; Ojalvo AG; Seralena A; Chinea G; Cruz LJ; de la Fuente J
    Biochem Biophys Res Commun; 1999 May; 259(1):162-8. PubMed ID: 10334933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat thrombolysis.
    Cross D
    Aust N Z J Med; 1993 Dec; 23(6):749-52. PubMed ID: 8141718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.
    Fears R; Ferres H; Glasgow E; Standring R; Hogg KJ; Gemmill JD; Burns JM; Rae AP; Dunn FG; Hillis WS
    Br Heart J; 1992 Aug; 68(2):167-70. PubMed ID: 1389731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet reactivity and streptokinase resistance following antecedent streptokinase therapy for myocardial infarction.
    Gorog DA; Ahmed N; Davies GJ
    Cardiology; 1999; 91(1):56-9. PubMed ID: 10393399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptokinase...never again.
    van de Werf F
    Eur Heart J; 1999 Sep; 20(17):1215. PubMed ID: 10454969
    [No Abstract]   [Full Text] [Related]  

  • 10. SK tray: a device to encourage streptokinase use.
    Saltiel E; Chun CO; Shane RR
    Am J Hosp Pharm; 1992 Jan; 49(1):136-7. PubMed ID: 1570856
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolysis for evolving myocardial infarction in a rural primary care clinic].
    Katz A; Caspi M; Zure N; Presma J; Shamai Z; Ovsyshcher I
    Harefuah; 1993 Jul; 125(1-2):11-3, 64, 63. PubMed ID: 8225057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postscript: fibrinolysis after acute myocardial infarction.
    Drug Ther Bull; 1991 Feb; 29(4):16. PubMed ID: 1935600
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary angioplasty vs thrombolysis in acute MI.
    Millard PS
    J Fam Pract; 1997 Jul; 45(1):21-2. PubMed ID: 9228907
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of treatment of acute myocardial infarction with thrombolytic therapy. Experiences in 437 patients in the coronary care unit of the National Institute of Cardiology "Ignacio Chavez"].
    Juárez Herrera U; Lasses y Ojeda LA; López MC; Chuquiure E; González Pacheco H; Carrillo Calvillo J; Martínez Sánchez C; Lupi Herrera E
    Arch Inst Cardiol Mex; 1998; 68(5):411-20. PubMed ID: 10365238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of thrombolytic therapy.
    Mair FS
    Am Fam Physician; 1996 Nov; 54(6):2041-8. PubMed ID: 8900363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction.
    Squire IB; Lawley W; Fletcher S; Holme E; Hillis WS; Hewitt C; Woods KL
    Eur Heart J; 1999 Sep; 20(17):1245-52. PubMed ID: 10454976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Repeat thrombolysis in acute myocardial infarction].
    Sychra M
    Vnitr Lek; 2002 Aug; 48(8):791-3. PubMed ID: 12425212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.